Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2019
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Takayasu syndrome
- Focus Therapeutic Use
- Acronyms TOCITAKA
- 16 Mar 2019 Status changed from recruiting to completed.
- 28 Aug 2017 Planned End Date changed from 1 Apr 2016 to 10 Dec 2019.
- 28 Aug 2017 Planned primary completion date changed from 1 Apr 2015 to 10 Dec 2018.